Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
20.06
-1.68 (-7.73%)
At close: Feb 18, 2026, 4:00 PM EST
20.28
+0.22 (1.10%)
After-hours: Feb 18, 2026, 7:50 PM EST
Prenetics Global Revenue
Prenetics Global had revenue of $23.56M in the quarter ending September 30, 2025, with 202.84% growth. This brings the company's revenue in the last twelve months to $77.08M, up 201.54% year-over-year. In the year 2024, Prenetics Global had annual revenue of $30.62M with 40.83% growth.
Revenue (ttm)
$77.08M
Revenue Growth
+201.54%
P/S Ratio
3.65
Revenue / Employee
$324,175
Employees
285
Market Cap
337.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.62M | 8.88M | 40.83% |
| Dec 31, 2023 | 21.74M | 8.58M | 65.17% |
| Dec 31, 2022 | 13.16M | 631.26K | 5.04% |
| Dec 31, 2021 | 12.53M | -52.65M | -80.77% |
| Dec 31, 2020 | 65.18M | 55.95M | 605.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 825.30M |
| OPKO Health | 642.07M |
| CareDx | 358.00M |
| Castle Biosciences | 343.53M |
| Fulgent Genetics | 315.55M |
| FONAR | 106.03M |
| MDxHealth | 103.07M |
| Biodesix | 80.17M |
PRE News
- 7 hours ago - Top Small-Cap Stocks Leading The Market Rotation - Seeking Alpha
- 11 hours ago - Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity - GlobeNewsWire
- 11 hours ago - Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY - GlobeNewsWire
- 1 day ago - Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors - GlobeNewsWire
- 5 days ago - Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder - GlobeNewsWire
- 4 weeks ago - Prenetics: Strong Liquidity And Rapidly Rising Revenue - Seeking Alpha
- 4 weeks ago - Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy) - Seeking Alpha
- 7 weeks ago - Buying bitcoin is no longer a thing for this David Beckham-backed health company - Market Watch